Consulting the Oracle of SARS-CoV-2 Infection

J Infect Dis. 2022 Apr 1;225(7):1115-1117. doi: 10.1093/infdis/jiab623.

Jacob E Lemieux^{1

2

3}, Jeremy Luban^{1

3

4

5

6}

¹ Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.
² Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Massachusetts Consortium on Pathogen Readiness, Boston, Massachusetts, USA.
⁴ Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁵ Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
⁶ Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.

No abstract available

Keywords: COVID-19; SARS-CoV-2; immunodeficiency; mutation; pandemic; spike; variants.

Publication types